Hypoaminotransferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal

Gastroenterology

Volumn 109, Issue 4, 1995, Pages 1295-1300

  Yasuda, Kazuto ^a   Okuda, Kunio ^b   Endo, Noriko ^a   Ishiwatari, Yukihisa ^a   Ikeda, Ritsuko ^a   Hayashi, Haruyuki ^c   Yokozeki, Kazuo ^c   Kobayashi, Susumu ^b   Irie, Yasubumi ^c  

^a TEIKYO UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c Sanai Memorial Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; PYRIDOXINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ERYTHROCYTE; HEMODIALYSIS; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0029093567     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90591-X     Document Type: Article

References (27)

1. Low aspartate transaminase activity in serum of patients undergoing hemodialysis
2. Decreased aspartate transaminase (“SGOT”) activity in serum of uremic patients
3. Observations on decreased serum glutamic oxalacetic transaminase (SGOT) activity in azotemic patients
4. Virological features of hepatitis C virus infection in hemodialysis patients
5. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays
6. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma
7. Hepatitis C markers in hemodialysis patients
8. Hepatitis C infection unrelated to blood transfusion in hemodialysis patients
9. The prevalence of anti-HCV antibodies in hemodialysis patients
10. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus
11. 6 deficiency in uremia and its implications for the depression of immune responses
12. 6 deficiency in uremia
13. Plasma pyridoxal-5′-phosphate levels and clinical correlation in chronic hemodialysis patients
14. 6 deficiency in maintenance dialysis patients: metabolic effects of repletion
15. Daily requirement for pyridoxine supplements in chronic renal failure
16. 6 requirement of patients on chronic peritoneal dialysis
17. 6 deficient uremic man
18. 6 deficiency
19. Expert panel on enzyme
20. Expert panel on enzyme
21. Recommendation for the measurement of human serum enzyme activity—aspartate aminotransferase (1989-08-30)
22. Recommendation for the measurement of human serum enzyme—alanine aminotransferase (1989-08-30)
23. 6 in the human
24. 6 compounds in plasma
25. 6
26. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients
27. Interferon treatment for chronic hepatitis C in hemodialysis patients—suggestions based on a small experience